Siegel D L, Silberstein L E
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Blood. 1994 Apr 15;83(8):2334-44.
The production of human anti-red blood cell (RBC) Igs in vitro from immunized individuals would greatly facilitate the genetic analysis of the human immune response to RBC antigens and also provide useful serologic reagents. Technical difficulties inherent in human B-cell immortalization have led to the development of molecular approaches that bypass the need for cell transformation. By cloning human Ig gene segments into bacterial expression vectors, libraries are created of filamentous phage particles displaying Fab fragments on their surfaces. Libraries have been screened with purified, soluble antigen and selected clones genetically manipulated in Escherichia coli to produce soluble Fab fragments. Our goal has been to adapt this technique to the study of RBC autoantibodies and alloantibodies that have specificities against unpurifiable membrane-bound antigens. To test the feasibility of this approach, two sets of phage were created, one set expressing a human anti-Rh(D) Ig and the other expressing a human antitetanus toxoid Ig. After verifying the presence of functional phage-displayed Fabs through biochemical, flow cytometric, and electron microscopic analyses, a model library was constructed comprising one anti-Rh(D)-expressing phage per 10(4) antitetanus toxoid-expressing phage. A method was developed for screening the library with intact Rh(D)-positive RBCs. After four rounds of panning, anti-Rh(D) specificity was enriched more than 10,000-fold to a final frequency of approximately 100%. Plasmid DNA derived from anti-Rh(D) phage was used to produce milligram quantities of soluble recombinant anti-Rh(D) Fabs purified by nitrogen cavitation and nickel-chelation affinity chromatography. The authenticity of the Fabs was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting, which showed bands with molecular weights of approximately 50 kD and 26 kD under nonreducing and reducing conditions, respectively. Binding of recombinant anti-Rh(D) Fabs to Rh(D)-positive RBCs was demonstrated by flow cytometry and by an agglutination assay. Our results suggest that repertoire cloning by cell-surface enrichment may have broad application to the study of the human immune response to erythroid antigens in addition to membrane-bound antigens present on other hematopoietic cells.
从免疫个体体外产生人抗红细胞(RBC)免疫球蛋白将极大地促进对人类针对RBC抗原的免疫反应的遗传分析,还能提供有用的血清学试剂。人类B细胞永生化所固有的技术难题促使了一些分子方法的发展,这些方法无需细胞转化。通过将人类免疫球蛋白基因片段克隆到细菌表达载体中,构建了丝状噬菌体颗粒文库,这些颗粒在其表面展示Fab片段。已用纯化的可溶性抗原筛选文库,并对在大肠杆菌中进行基因操作的选定克隆进行处理以产生可溶性Fab片段。我们的目标是将该技术应用于对具有针对不可纯化的膜结合抗原的特异性的RBC自身抗体和同种抗体的研究。为了测试该方法的可行性,创建了两组噬菌体,一组表达人抗Rh(D)免疫球蛋白,另一组表达人抗破伤风类毒素免疫球蛋白。通过生化、流式细胞术和电子显微镜分析验证了功能性噬菌体展示的Fabs的存在后,构建了一个模型文库,每10⁴个表达抗破伤风类毒素的噬菌体中包含一个表达抗Rh(D)的噬菌体。开发了一种用完整的Rh(D)阳性RBC筛选文库的方法。经过四轮淘选,抗Rh(D)特异性富集了超过10000倍,最终频率约为100%。源自抗Rh(D)噬菌体的质粒DNA用于通过氮空化和镍螯合亲和色谱法生产毫克量的可溶性重组抗Rh(D)Fabs。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和免疫印迹证实了Fabs的真实性,结果显示在非还原和还原条件下分子量分别约为50 kD和26 kD的条带。通过流式细胞术和凝集试验证明了重组抗Rh(D)Fabs与Rh(D)阳性RBC的结合。我们的结果表明,除了存在于其他造血细胞上的膜结合抗原外,通过细胞表面富集进行的文库克隆可能在人类针对红系抗原的免疫反应研究中有广泛应用。